[HTML][HTML] Epidermal growth factor receptor mutation (EGFR) testing for prediction of response to EGFR-targeting tyrosine kinase inhibitor (TKI) drugs in patients with …
MA Secretariat - Ontario health technology assessment series, 2010 - ncbi.nlm.nih.gov
MA Secretariat
Ontario health technology assessment series, 2010•ncbi.nlm.nih.govExecutive Summary In February 2010, the Medical Advisory Secretariat (MAS) began work
on evidence-based reviews of the literature surrounding three pharmacogenomic tests. This
project came about when Cancer Care Ontario (CCO) asked MAS to provide evidence-
based analyses on the effectiveness and cost-effectiveness of three oncology
pharmacogenomic tests currently in use in Ontario. Evidence-based analyses have been
prepared for each of these technologies. These have been completed in conjunction with …
on evidence-based reviews of the literature surrounding three pharmacogenomic tests. This
project came about when Cancer Care Ontario (CCO) asked MAS to provide evidence-
based analyses on the effectiveness and cost-effectiveness of three oncology
pharmacogenomic tests currently in use in Ontario. Evidence-based analyses have been
prepared for each of these technologies. These have been completed in conjunction with …
Executive Summary
In February 2010, the Medical Advisory Secretariat (MAS) began work on evidence-based reviews of the literature surrounding three pharmacogenomic tests. This project came about when Cancer Care Ontario (CCO) asked MAS to provide evidence-based analyses on the effectiveness and cost-effectiveness of three oncology pharmacogenomic tests currently in use in Ontario.
Evidence-based analyses have been prepared for each of these technologies. These have been completed in conjunction with internal and external stakeholders, including a Provincial Expert Panel on Pharmacogenetics (PEPP). Within the PEPP, subgroup committees were developed for each disease area. For each technology, an economic analysis was also completed by the Toronto Health Economics and Technology Assessment Collaborative (THETA) and is summarized within the reports.
ncbi.nlm.nih.gov